Federal Initiative to Guarantee Health by Targeting Fentanyl Act

Bill: 116-s-2701
Sponsor: full_name: Sen. Portman, Rob [R-OH]
Introduced: 2019-10-24
Policy area: Crime and Law Enforcement
Subjects: Drug trafficking and controlled substances
Latest action: action_date: 2019-10-24
text: Read twice and referred to the Committee on the Judiciary.

Summaries:
action_date: 2019-10-24
action_desc: Introduced in Senate
text: <p><b>Federal Initiative to Guarantee Health by Targeting Fentanyl Act</b></p> <p>This bill adds the entire category of fentanyl-related substances to schedule I of the Controlled Substances Act. A schedule I controlled substance is a drug, substance, or chemical that has a high potential for abuse; has no currently accepted medical value; and is subject to regulatory controls and administrative, civil, and criminal penalties under the Controlled Substances Act.</p>

tv_txt: II 116th CONGRESS 1st Session S. 2701 IN THE SENATE OF THE UNITED STATES October 24, 2019 Mr. Portman (for himself and Mr. Manchin ) introduced the following bill; which was read twice and referred to the Committee on the Judiciary A BILL To amend the Controlled Substances Act to list fentanyl-related substances as schedule I controlled substances.

1. Short title This Act may be cited as the Federal Initiative to Guarantee Health by Targeting Fentanyl Act . 2. Fentanyl-related substances Schedule I of section 202(c) of the Controlled Substances Act ( 21 U.S.C. 812(c) ) is amended by adding at the end the following: (e)(1) Unless specifically exempted or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of fentanyl-related substances, or which contains their salts, isomers, and salts of isomers whenever the existence of such salts, isomers, and salts of isomers is possible within the specific chemical designation. (2) In paragraph (1), the term fentanyl-related substances includes any substance that is structurally related to fentanyl by 1 or more of the following modifications: (A) By replacement of the phenyl portion of the phenethyl group by any monocycle, whether or not further substituted in or on the monocycle. (B) By substitution in or on the phenethyl group with alkyl, alkenyl, alkoxyl, hydroxyl, halo, haloalkyl, amino, or nitro groups. (C) By substitution in or on the piperidine ring with alkyl, alkenyl, alkoxyl, ester, ether, hydroxyl, halo, haloalkyl, amino, or nitro groups. (D) By replacement of the aniline ring with any aromatic monocycle whether or not further substituted in or on the aromatic monocycle. (E) By replacement of the N-propionyl group by another acyl group. .